Delivery Order SPE2DB22D3501-SPE2DB24FVU39
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of INFUVITE PEDIATRIC VIAL 5ML, a critical medical product, to support federal healthcare programs. The contract has a ceiling value of $4,101.77 and is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of INFUVITE PEDIATRIC VIAL 5ML pharmaceutical products. The contract has a ceiling value of $21,151.36 and runs through September 5, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 4, 2025. The $8,014.00 firm-fixed-price delivery order is for the supply of INFUVITE PEDIATRIC VIAL 5ML medical products. The contract has an ultimate completion date of February 5, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of INFUVITE PEDIATRIC VIAL 5ML. The contract has a ceiling value of $16,121.10 and an ultimate completion date of August 5, 2024. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen has been a significant supplier of pharmaceutical products and medical supplies to various federal agencies, including...
- The Defense Logistics Agency (DLA) awarded a $25.8K delivery order to AmerisourceBergen Drug Corp for INFUVITE PEDIATRIC VIAL 5ML, a pediatric intravenous nutritional product. Issued on June 11, 2025, with an ultimate completion date of June 12, 2025, this firm fixed-price delivery order represents a non-set-aside competitive award. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a $10,191.98 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of INFUVITE ADULT VIAL 10ML medical products. The contract has an ultimate completion date of May 27, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
- This is a $5,876.47 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFUVITE ADULT VIAL 10ML medical supplies, with a period of performance through July 1, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award made by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFUVITE PEDIATRIC VIAL 5ML, a medical product. The contract has a ceiling value of $11,605.35 and is a firm fixed price delivery order. It is not designated as a set-aside contract. The contract has an ultimate completion date of July 14,...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,744.67 firm fixed-price contract is for the delivery of INFUVITE ADULT VIAL 10ML medical products. The contract has a completion date of July 9, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
- The Defense Logistics Agency awarded a delivery order valued at $19,211.16 to AmerisourceBergen Drug Corp for Infuvite Pediatric Vial 5ML, a pediatric parenteral nutrition product. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and was competitively awarded without a set-aside designation. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVU39Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp., a major pharmaceutical distribution company, for the supply of INFUVITE PEDIATRIC VIAL 5ML medical products. The contract has a firm fixed price of $9,194.69 and a completion date of May 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables the DLA to efficiently procure essential medical commodities, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials, for military treatment programs and facilities globally. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 5/28/24 |